SyzalterinCAS# 94451-48-6 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 94451-48-6 | SDF | Download SDF |
| PubChem ID | 15698703 | Appearance | Yellow powder |
| Formula | C17H14O5 | M.Wt | 298.3 |
| Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | 5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-dimethylchromen-4-one | ||
| SMILES | CC1=C(C2=C(C(=C1O)C)OC(=CC2=O)C3=CC=C(C=C3)O)O | ||
| Standard InChIKey | VDYGMHWAKRDYQR-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C17H14O5/c1-8-15(20)9(2)17-14(16(8)21)12(19)7-13(22-17)10-3-5-11(18)6-4-10/h3-7,18,20-21H,1-2H3 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Syzalterin can protect PC12 cells effectively against Abeta-induced toxicity. |
| Targets | Beta Amyloid |
Syzalterin Dilution Calculator
Syzalterin Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.3523 mL | 16.7616 mL | 33.5233 mL | 67.0466 mL | 83.8082 mL |
| 5 mM | 0.6705 mL | 3.3523 mL | 6.7047 mL | 13.4093 mL | 16.7616 mL |
| 10 mM | 0.3352 mL | 1.6762 mL | 3.3523 mL | 6.7047 mL | 8.3808 mL |
| 50 mM | 0.067 mL | 0.3352 mL | 0.6705 mL | 1.3409 mL | 1.6762 mL |
| 100 mM | 0.0335 mL | 0.1676 mL | 0.3352 mL | 0.6705 mL | 0.8381 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Bacopaside X
Catalog No.:BCC8126
CAS No.:94443-88-6
- BKM120
Catalog No.:BCC1279
CAS No.:944396-07-0
- JNJ 28871063 hydrochloride
Catalog No.:BCC7662
CAS No.:944342-90-9
- QS 11
Catalog No.:BCC7648
CAS No.:944328-88-5
- A-803467
Catalog No.:BCC5075
CAS No.:944261-79-4
- MJ 15
Catalog No.:BCC7852
CAS No.:944154-76-1
- Peficitinb (ASP015K, JNJ-54781532)
Catalog No.:BCC6503
CAS No.:944118-01-8
- PG 106
Catalog No.:BCC6330
CAS No.:944111-22-2
- Isomartynoside
Catalog No.:BCN4497
CAS No.:94410-22-7
- Tetrachlorohydroquinone dimethyl ether
Catalog No.:BCN1301
CAS No.:944-78-5
- Dimethylmatairesinol
Catalog No.:BCN4496
CAS No.:943989-68-2
- BMS-303141
Catalog No.:BCC4097
CAS No.:943962-47-8
- Cromakalim
Catalog No.:BCC7038
CAS No.:94470-67-4
- Lck inhibitor 2
Catalog No.:BCC1690
CAS No.:944795-06-6
- Rhuscholide A
Catalog No.:BCN4498
CAS No.:944804-58-4
- Isodaphnoretin B
Catalog No.:BCN6913
CAS No.:944824-29-7
- Decernotinib(VX-509)
Catalog No.:BCC6456
CAS No.:944842-54-0
- Angelic anhydride
Catalog No.:BCN3411
CAS No.:94487-74-8
- 2'-Acetylacteoside
Catalog No.:BCN3409
CAS No.:94492-24-7
- Tamibarotene
Catalog No.:BCC1983
CAS No.:94497-51-5
- CYM 5541
Catalog No.:BCC6321
CAS No.:945128-26-7
- 7-Prenyljacareubin
Catalog No.:BCN7353
CAS No.:94513-60-7
- 4-Hydroxy-2-methoxyphenol 1-O-(6-O-syringoyl)glucoside
Catalog No.:BCN1300
CAS No.:945259-61-0
- 3,4-Dihydro-6,7-(methylenedioxy)-2(1H)-quinolinone
Catalog No.:BCN1299
CAS No.:94527-34-1
Identification and characterization of three new flavonoids from Rhododendron dauricum.[Pubmed:26253496]
Chin J Nat Med. 2015 Aug;13(8):628-33.
The present study was designed to determine the major chemical constituents of the leaves of Rhododendron dauricum L. Compounds were isolated and purified by various chromatographic methods, and their structures were elucidated by physicochemical properties and spectral data. The present study identified two new C-methyl flavanones, 5, 7, 3', 5'-tetrahydroxy-6, 8-di-C-methyl flavanone (1) and 5, 4'-dihydroxy-8-C-methylflavanone-7-O-beta-D-glucopyranoside (2), and one new flavonoid glycoside, quercetin-3-O-beta-D-(6"-O-cinnamoyl)-galactoside (3), along with seven known compounds, including Syzalterin (4), poriolin (5), farrerol-7-O-beta-D-glucopyranoside (6), myrciacetin (7), quercetin-3-O-beta-D-(6-p-hydroxy-benzoyl)-galactoside (8), quercetin-3-O-beta-D-(6-p-coumaroyl)-galactoside (9), and 5, 7, 3', 5'-tetrahydroxyl flavanone (10). Compounds 1-3 were determined to be new flavonoids; compounds 4-6 were isolated from this species for the first time; and compounds 7-10 were reported for the first time from this genus.
C-methylflavonoids isolated from Callistemon lanceolatus protect PC12 cells against Abeta-induced toxicity.[Pubmed:20101562]
Planta Med. 2010 Jun;76(9):863-8.
Increased beta-amyloid (Abeta) production and its aggregation to the oligomeric state is considered to be a major cause of Alzheimer's disease (AD). Therefore, reducing Abeta-induced neurotoxicity could provide a suitable means of prevention or intervention in the disease course of AD. The neuroprotective effects of isolates from Callistemon lanceolatus DC. (Myrtaceae) against Abeta were evaluated using PC12 cells. To evaluate the effects of Abeta on apoptotic cell death and the effects of Bcl-2 family proteins and caspase-3, TUNEL assays and Western blotting were performed, respectively. Substantial fractionation and purification of the EtOAc-soluble extract of the aerial parts of C. lanceolatus afforded six flavonoids, 4',5-dihydroxy-6,8-dimethyl-7-methoxyflavanone (1), eucalyptin (2), 8-demethyleucalyptin (3), sideroxylin (4), Syzalterin (5), and quercetin (6). Compounds 1, 5, and 6 were found to protect PC12 cells effectively against Abeta-induced toxicity. In particular, compound 1 showed the most promising neuroprotective effect with an ED (50) value of 6.7 microM in terms of decreasing Abeta-induced apoptotic cell death, and this was accompanied by a decrease in caspase-3 activation and an increase in Bcl-2/Bax ratio. These results suggest that compound 1 could be developed as a candidate anti-AD agent due to its attenuation of Abeta-induced apoptotic cell death.
